English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Trytosaveabit commented on a stock · Nov 25, 2024 23:03

Update

$Immix Biopharma (IMMX.US)$ Immix Biopharma Presents Positive NXC-201 Clinical Data at 66th American Society of Hematology (ASH) Annual Meeting in 16 Relapsed/Refractory AL Amyloidosis Patients
GlobeNewswire·
75% (12/16) complete response rate observed in relapsed/refractory AL Amyloidosis patients with median 4 prior lines of therapy
Data will be presented on Monday, December 9, 2024 at 4:00 PM PT
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2463 Views
Comment
Sign in to post a comment
    avatar
    Trytosaveabit
    4919
    Followers
    24
    Following
    70K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartPrice
    NVDA
    NVIDIA
    -- 138.850
    GRAB
    Grab Holdings
    -- 4.900
    TSLA
    Tesla
    -- 355.840
    INTC
    Intel
    -- 23.600
    BABA
    Alibaba
    -- 124.730
    Discussing
    Trump 2.0 Era: How will global markets evolve?
    🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
    MicroStrategy Q4 2024 earnings conference call
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.